Imaging in Therapy Response Assessment and Surveillance of Lung Cancer: Evidenced-based Review With Focus on the Utility of 18F-FDG PET/CT

Research output: Contribution to journalReview articlepeer-review

Abstract

This review covers the state-of-the-art imaging in therapy assessment and surveillance of lung cancer with focus on the utility of fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT). We review different qualitative and quantitative response assessment criteria in lung cancer, common pitfalls and atypical patterns of response to immunotherapy, and imaging features of common immune-related adverse events. In addition, the currently recommended imaging workup in surveillance of asymptomatic patients with non–small-cell and small-cell lung cancer and future developments will be discussed.

Original languageEnglish (US)
Pages (from-to)485-497
Number of pages13
JournalClinical lung cancer
Volume21
Issue number6
DOIs
StatePublished - Nov 2020

Keywords

  • F-FDG PET/CT
  • Non–small-cell lung cancer
  • Small-cell lung cancer
  • Surveillance
  • Therapy assessment

ASJC Scopus subject areas

  • Oncology
  • Pulmonary and Respiratory Medicine
  • Cancer Research

Fingerprint Dive into the research topics of 'Imaging in Therapy Response Assessment and Surveillance of Lung Cancer: Evidenced-based Review With Focus on the Utility of <sup>18</sup>F-FDG PET/CT'. Together they form a unique fingerprint.

Cite this